Basilea Pharmaceutica Ltd (BPMUF)
44.45
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Basilea Pharmaceutica Shareholders Equity (Quarterly): -11.91M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.91M |
| June 30, 2023 | 16.67M |
| June 30, 2023 | 16.67M |
| December 31, 2022 | -22.34M |
| June 30, 2022 | -70.38M |
| June 30, 2022 | -70.38M |
| December 31, 2021 | -64.11M |
| June 30, 2021 | -85.51M |
| June 30, 2021 | -85.51M |
| December 31, 2020 | -116.80M |
| June 30, 2020 | -83.67M |
| June 30, 2020 | -83.67M |
| December 31, 2019 | -95.94M |
| June 30, 2019 | -81.88M |
| June 30, 2019 | -81.88M |
| December 31, 2018 | -67.73M |
| June 30, 2018 | -58.36M |
| June 30, 2018 | -58.36M |
| December 31, 2017 | -42.54M |
| June 30, 2017 | -53.01M |
| June 30, 2017 | -53.01M |
| Date | Value |
|---|---|
| December 31, 2016 | -34.40M |
| June 30, 2016 | -9.157M |
| June 30, 2016 | -9.157M |
| December 31, 2015 | 15.03M |
| June 30, 2015 | 47.56M |
| June 30, 2015 | 47.56M |
| December 31, 2014 | 58.59M |
| June 30, 2014 | 80.91M |
| June 30, 2014 | 80.91M |
| December 31, 2013 | 79.86M |
| June 30, 2013 | 45.59M |
| June 30, 2013 | 45.59M |
| December 31, 2012 | 115.57M |
| June 30, 2012 | 125.64M |
| June 30, 2012 | 125.64M |
| December 31, 2011 | 162.96M |
| June 30, 2011 | 231.52M |
| December 31, 2010 | 224.92M |
| June 30, 2010 | 72.68M |
| December 31, 2009 | 94.37M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-116.80M
Minimum
Dec 2020
16.67M
Maximum
Jun 2023
-61.38M
Average
-81.88M
Median
Jun 2019
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 160.35M |
| CRISPR Therapeutics AG | 2.084B |
| Addex Therapeutics Ltd | 1.364M |
| NLS Pharmaceutics Ltd | -8.834M |
| Molecular Partners AG | 210.05M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 206.31M |
| Total Liabilities (Quarterly) | 218.22M |
| Debt to Equity Ratio | -11.09 |
| Current Ratio | 3.197 |
| Net Debt Paydown Yield | 6.10% |